This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

The Growing Cost Of Aging: Express Scripts Study Shows Medication Use For Normal Aging Conditions Overtakes Costs Of Treating Most Chronic Diseases









ST. LOUIS, Oct. 30, 2012 /PRNewswire/ -- Prescription-drug treatment regimens for conditions that are a normal part of aging are now costing the nation more than many serious and potentially life-threatening diseases, according to new research from Express Scripts (NASDAQ: ESRX).

(Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

A study, presented today at the annual meeting of the American Public Health Association (APHA) in San Francisco, finds that in 2011 spending on medications for aging conditions — such as mental alertness, sexual dysfunction, menopause, aging skin and hair loss — ranked third in annual prescription-drug costs of the commercially insured, surpassed only by the cost of treating diabetes and high cholesterol.  

The research found that among these insured individuals use of drugs to treat the physical impact associated with normal aging was up 18.5 percent and costs increased nearly 46 percent from 2006 to 2011. Increased use of these drugs was even more pronounced for the Medicare population (age 65+), up 32 percent from 2007 to 2011. The largest utilization jump among Medicare beneficiaries was from 2010 to 2011, up more than 13 percent and outpacing increases in the use of drugs for diabetes, high cholesterol and high blood pressure combined.

"There is no doubt that pharmaceutical advances and greater awareness have improved the quality of life for many aging Americans," said Dr. Glen Stettin, Express Scripts senior vice president of Clinical, Research and New Solutions. "What was not known, until now, is the significant cost associated with treating these conditions. Couple that with the proliferation of people living longer and it's clear that monitoring and managing the trend and spend from treating conditions associated with aging will become increasingly important."

In 2011 alone, more than $73.3 million was spent for every 1 million commercially insured individuals, and the cost was nearly $90 million per 1 million Medicare members on these aging-related medications.

The United States is in the midst of a profound demographic change, with the number of elderly people projected to reach nearly 20 percent of the entire population by 2030, up from less than 13 percent in 2009. This increase will continue to drive both use and costs of medications to treat the natural conditions of aging.

The study also showed that while utilization and drug costs were highest among older commercially insured individuals, the greatest growth in cost per insured was seen among the 45 to 54 age group — up almost 21 percent over the five-year period.

Stock quotes in this article: ESRX 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs